In this context, insulin-sensitizing drugs like metformin (the first-line of treatment for PCOS patients with insulin resistance) are able to decrease chemerin serum levels and inhibit the harmful effects of hyperinsulinemia (Yen et al., 2021[55]). Here, INS is linked to polycystic ovary syndrome.